The Oncosearch | Oncotarget

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma Research Paper

Laila Babar, Juliann E. Kosovec, Vida Jahangiri, Nobel Chowdhury, Ping Zheng, Ashten N. Omstead, Madison S. Salvitti, Matthew A. Smith, Ajay Goel, Ronan J. Kelly, Blair A. Jobe, Ali H. Zaidi

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4546-4555

Keywords: esophageal adenocarcinoma, LAG3, IDO1, CXCL9, TIM3

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition Research Paper

Oluseyi Ayinde, Zhuo Wang, Giulia Pinton, Laura Moro, Martin Griffin

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4556-4569

Keywords: transglutaminase 2, colorectal cancer, epithelial-mesenchymal transition, cancer Stem Cells, β-catenin

Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction Research Paper

Daniel Bug, Friedrich Feuerhake, Eva Oswald, Julia Schüler, Dorit Merhof

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4587-4597

Keywords: deep learning, digital pathology, histology, non small cell lung cancer, xenograft

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes Research Paper

Antonio Gil-Moreno, Melchor Carbonell-Socias, Sabina Salicrú, Melissa Bradbury, Ángel García, Ramona Vergés, Oriol Puig Puig, José Luís Sánchez-Iglesias, Silvia Cabrera-Díaz, Javier de la Torre, Natalia R. Gómez-Hidalgo, Assumpció Pérez-Benavente, Berta Díaz-Feijoo

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4598-4608

Keywords: cervical cancer, morbidity, recurrence, surgical treatment, survival

The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment Research Paper

Stephen G. Gaffney, Elizabeth B. Perry, Ping-Min Chen, Andrew Greenstein, Susan M. Kaech, Jeffrey P. Townsend

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4532-4545

Keywords: immunotherapy, tumor microenvironment, T lymphocyte, cancer genomics, RNA-seq

Real-world evidence to guide healthcare policies in oncology Research Perspective

Marco Donia, Steen Werner Hansen, Inge Marie Svane

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4513-4515

Keywords: real-world evidence, real-world data, clinical trial eligibility

Adding genetic scores to risk models in colorectal cancer Editorial

Carla J. Gargallo-Puyuelo, Ángel Lanas, María Asunción García-Gonzalez

Published Jul 15, 2019 · Vol. 10, No. 47 · pp. 4803-4804

Keywords: colorectal cancer, colorectal adenoma, genetic risk score, prediction risk models

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Correction

Minakshi Mann, Sachin Kumar, Shyam S. Chauhan, Neerja Bhatla, Sunesh Kumar, Sameer Bakhshi, Ritu Gupta, Ashok Sharma, Lalit Kumar

Published Jul 12, 2019 · Vol. 10, No. 46 · pp. 4802-4802

Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells Research Paper

Elvin Peter Chizenga, Rahul Chandran, Heidi Abrahamse

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4380-4396

Keywords: photodynamic therapy, cervical cancer, cancer stem cells, photosensitizer, cancer resistance

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Feng-Mao Lin, Susan E. Yost, Wei Wen, Paul H. Frankel, Daniel Schmolze, Pei-Guo Chu, Yate-Ching Yuan, Zheng Liu, John Yim, Zhen Chen, Yuan Yuan

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4356-4368

Keywords: AKT, differential expression, AKT targeting, TNBC

Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer Research Paper

Laris Achlaug, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Ilan Bruchim, Manisha Dixit, Zvi Laron, Shoshana Yakar, Haim Werner

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4437-4448

Keywords: insulin-like growth factor-1 (IGF1), IGF1 receptor, ZYG11A, p53, endometrial cancer

CD90^low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer Research Paper

Yang Zeng, Binghao Li, Tao Li, Wei Liu, Chongzhao Ran, Richard T. Penson, Mark C. Poznansky, Yanan Du, Huabiao Chen

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4479-4491

Keywords: mesenchymal stem cells, CD90, ovarian cancer, immunotherapy

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme Research Paper

Yvonne Becker, Sarah Förster, Gerrit H. Gielen, Ian Loke, Morten Thaysen-Andersen, Christine Laurini, Kristin Wehrand, Torsten Pietsch, Simone Diestel

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4449-4465

Keywords: cancer progression, glioblastoma multiforme, N-glycosylation, paucimannosidic epitopes, AHNAK

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study Research Paper

Dorte Schou Nørøxe, Olga Østrup, Christina Westmose Yde, Lise Barlebo Ahlborn, Finn Cilius Nielsen, Signe Regner Michaelsen, Vibeke Andrée Larsen, Jane Skjøth-Rasmussen, Jannick Brennum, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4397-4406

Keywords: glioblastoma, liquid biopsy, cell-free DNA, fragment length, base-pair

Dicer prevents genome instability in response to replication stress Research Paper

Michalis Fragkos, Viviana Barra, Tom Egger, Benoit Bordignon, Delphine Lemacon, Valeria Naim, Arnaud Coquelle

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4407-4423

Keywords: replication stress, common fragile sites, Dicer, genomic instability

Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease Review

Luigi Maiuri, Valeria Raia, Mauro Piacentini, Antonella Tosco, Valeria Rachela Villella, Guido Kroemer

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4492-4500

Keywords: CFTR, cystic fibrosis, autophagy, celiac disease, transglutaminase 2

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Elgilda Musi, Gary K. Schwartz, Jae Hyuk Yoo, Shannon J. Odelberg, Dean Y. Li, Michael Y. Bonner, Ponniah Selvakumar, Shikha Rao, Linda C. Gilbert, Justin Elsey, Jack L. Arbiser

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4424-4436

Keywords: melanoma, chemotherapy

Age-dependent response to multimodal therapy for stage II-III rectal cancer Editorial

Daniel Delitto, Tyler J. Loftus, Atif Iqbal

Published Jul 6, 2019 · Vol. 10, No. 45 · pp. 4615-4615

Keywords: young, rectal cancer, survival, age

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Stephen L. Luen, Roberto Salgado, Sherene Loi

Published Jul 4, 2019 · Vol. 10, No. 45 · pp. 4612-4614

Keywords: triple negative breast cancer, tumor infiltrating lymphocytes, neoadjuvant chemotherapy, prognosis

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Research Paper

Minakshi Mann, Sachin Kumar, Shyam S. Chauhan, Neerja Bhatla, Sunesh Kumar, Sameer Bakhshi, Ritu Gupta, Ashok Sharma, Lalit Kumar

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4262-4275

Keywords: cervical cancer, cisplatin, PARP-1, PJ34, β-catenin

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma Research Paper

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition Research Paper

Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction Research Paper

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes Research Paper

The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment Research Paper

Real-world evidence to guide healthcare policies in oncology Research Perspective

Adding genetic scores to risk models in colorectal cancer Editorial

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Correction

Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells Research Paper

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer Research Paper

CD90^low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer Research Paper

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme Research Paper

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study Research Paper

Dicer prevents genome instability in response to replication stress Research Paper

Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease Review

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Age-dependent response to multimodal therapy for stage II-III rectal cancer Editorial

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma Research Paper

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition Research Paper

Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction Research Paper

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes Research Paper

The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment Research Paper

Real-world evidence to guide healthcare policies in oncology Research Perspective

Adding genetic scores to risk models in colorectal cancer Editorial

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Correction

Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells Research Paper

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer Research Paper

CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer Research Paper

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme Research Paper

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study Research Paper

Dicer prevents genome instability in response to replication stress Research Paper

Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease Review

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Age-dependent response to multimodal therapy for stage II-III rectal cancer Editorial

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Research Paper

CD90^low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer Research Paper